Literature DB >> 17471297

INSIG2 gene polymorphism is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects.

A J P Smith1, J A Cooper, L K Li, S E Humphries.   

Abstract

A common polymorphism, rs7566605, 10 kb upstream of the insulin-induced gene 2 transcription start site has been associated with obesity in Caucasian and African-American populations, with the hypothesis that an alteration in gene expression results in elevated plasma triglyceride levels. The goal of this study was to verify the findings in a cohort of 2721 healthy Caucasian men (second Northwick Park Heart Study), and a separate study of 747 type 2 diabetic patients from Caucasian, Afro-Caribbean and Indian groups (University College London Diabetes and Cardiovascular Disease Study). The rs7566605 single-nucleotide polymorphism (SNP) was not related to plasma triglyceride levels in either study, and we found no association with body mass index or obesity in either cohort, despite having the power to detect the previously reported effect. This suggests that, at the least, the true size of the effect on obesity of this SNP is likely to be considerably less than reported previously.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471297     DOI: 10.1038/sj.ijo.0803645

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  24 in total

1.  A tagging SNP in INSIG2 is associated with obesity-related phenotypes among Samoans.

Authors:  Ranjan Deka; Ling Xu; Prodipto Pal; Palanitina T Toelupe; Tuiasina S Laumoli; Huifeng Xi; Ge Zhang; Daniel E Weeks; Stephen T McGarvey
Journal:  BMC Med Genet       Date:  2009-12-22       Impact factor: 2.103

2.  INSIG2 is Associated with Lower Gain in Weight-for-Length Between Birth and Age 6 Months.

Authors:  Ann Chen Wu; Matthew W Gillman; Elsie M Taveras; Augusto A Litonjua
Journal:  Clin Med Pediatr       Date:  2009

3.  Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent.

Authors:  Kimberly A Skelding; Glenn S Gerhard; Helen Vlachos; Faith Selzer; Sheryl F Kelsey; Xin Chu; Robert Erdman; David O Williams; Kevin E Kip
Journal:  BMC Cardiovasc Disord       Date:  2010-09-29       Impact factor: 2.298

4.  The INSIG2 rs7566605 polymorphism is not associated with body mass index and breast cancer risk.

Authors:  Daniele Campa; Anika Hüsing; James D McKay; Olga Sinilnikova; Ulla Vogel; Anne Tjønneland; Kim Overvad; Jakob Stegger; Françoise Clavel-Chapelon; Nathalie Chabbert-Buffet; Guy Fagherazzi; Antonia Trichopoulou; Dimosthenis Zylis; Erifili Oustoglou; Sabine Rohrmann; Birgit Teucher; Eva Fisher; Heiner Boeing; Giovanna Masala; Vittorio Krogh; Carlotta Sacerdote; Salvatore Panico; Rosario Tumino; N Charlotte Onland-Moret; Carla H van Gils; H Bas Bueno-de-Mesquita; Eiliv Lund; María Dolores Chirlaque; Núria Sala; José Ramon Quirós; Eva Ardanaz; Pilar Amiano; Esther Molina-Montes; Göran Hallmans; Per Lenner; Ruth C Travis; Timothy J Key; Nick Wareham; Kay-Tee Khaw; Sabina Rinaldi; Nadia Slimani; Veronique Chajes; Afshan Siddiq; Elio Riboli; Rudolf Kaaks; Federico Canzian
Journal:  BMC Cancer       Date:  2010-10-18       Impact factor: 4.430

5.  INSIG2 variants, dietary patterns and metabolic risk in Samoa.

Authors:  A Baylin; R Deka; J Tuitele; S Viali; D E Weeks; S T McGarvey
Journal:  Eur J Clin Nutr       Date:  2012-09-12       Impact factor: 4.016

6.  Possible role for ENPP1 polymorphism in obesity but not for INSIG2 and PLIN variants.

Authors:  Armand Peeters; Sigri Beckers; An Verrijken; Ilse Mertens; Luc Van Gaal; Wim Van Hul
Journal:  Endocrine       Date:  2009-04-28       Impact factor: 3.633

7.  Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.

Authors:  Yuka Takahama; Hirofumi Uto; Shuji Kanmura; Makoto Oketani; Akio Ido; Kazunori Kusumoto; Satoru Hasuike; Kenji Nagata; Katsuhiro Hayashi; Sherri Stuver; Akihiko Okayama; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

8.  The INSIG2 rs7566605 genetic variant does not play a major role in obesity in a sample of 24,722 individuals from four cohorts.

Authors:  Jan Bressler; Myriam Fornage; Craig L Hanis; Wen Hong Linda Kao; Cora E Lewis; Ruth McPherson; Robert Dent; Thomas H Mosley; Len A Pennacchio; Eric Boerwinkle
Journal:  BMC Med Genet       Date:  2009-06-12       Impact factor: 2.103

9.  Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design?

Authors:  Iris M Heid; Cornelia Huth; Ruth J F Loos; Florian Kronenberg; Vera Adamkova; Sonia S Anand; Kristin Ardlie; Heike Biebermann; Peter Bjerregaard; Heiner Boeing; Claude Bouchard; Marina Ciullo; Jackie A Cooper; Dolores Corella; Christian Dina; James C Engert; Eva Fisher; Francesc Francès; Philippe Froguel; Johannes Hebebrand; Robert A Hegele; Anke Hinney; Margret R Hoehe; Frank B Hu; Jaroslav A Hubacek; Steve E Humphries; Steven C Hunt; Thomas Illig; Marjo-Riita Järvelin; Marika Kaakinen; Barbara Kollerits; Heiko Krude; Jitender Kumar; Leslie A Lange; Birgit Langer; Shengxu Li; Andreas Luchner; Helen N Lyon; David Meyre; Karen L Mohlke; Vincent Mooser; Almut Nebel; Thuy Trang Nguyen; Bernhard Paulweber; Louis Perusse; Lu Qi; Tuomo Rankinen; Dieter Rosskopf; Stefan Schreiber; Shantanu Sengupta; Rossella Sorice; Anita Suk; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Henry Völzke; Karani S Vimaleswaran; Nicholas J Wareham; Dawn Waterworth; Salim Yusuf; Cecilia Lindgren; Mark I McCarthy; Christoph Lange; Joel N Hirschhorn; Nan Laird; H-Erich Wichmann
Journal:  PLoS Genet       Date:  2009-10-23       Impact factor: 5.917

10.  Association analyses of the INSIG2 polymorphism in the obesity and cholesterol levels of Korean populations.

Authors:  Seongwon Cha; Imhoi Koo; Sun Mi Choi; Byung Lae Park; Kil Soo Kim; Jae-Ryong Kim; Hyoung Doo Shin; Jong Yeol Kim
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.